FDA approves generic copy of Remeron anti-depressant

12/19/2003 | Forbes

Barr Laboratories announced the FDA approved its generic version of Akzo Nobel's Remeron, a drug to treat depression. With the approval, Barr has exclusive rights to sell its Soltab in the U.S. for the next six months.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ